Medicines Shortages: Regulatory Processes to Manage Supply Disruptions

On 23 May 2022 the UK MHRA published the guidance on regulatory processes to manage supply disruptions.

New applications for Marketing Authorisations and product variations can be fast tracked if there is compelling evidence of benefit in a public health emergency or if there is a shortage of supply of an essential medicine that has been verified by the Department of Health and Social Care.

Read more online 
Copyright Widler & Schiemann AG 2020. All Rights Reserved. /